Form 4: Hims & Hers Health CFO Oluyemi Okupe Executes Stock Option and Sells Shares
SEC Form 4
Hims & Hers Health CFO Oluyemi Okupe exercised stock options and sold shares of Class A Common Stock on October 2, 2024, according to a Form 4 filing with the SEC.
Summary
- On October 2, 2024, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., exercised stock options to acquire 6,437 shares of Class A Common Stock at a price of $5.01 per share.
- Okupe then sold a total of 12,578 shares of Class A Common Stock in four separate transactions at weighted average prices ranging from $18.8815 to $19.0815.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 31, 2024.
- Following these transactions, Okupe directly owns 205,856 shares of Class A Common Stock and holds options to purchase 827,847 shares.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. The CFO exercised options and sold shares under a pre-arranged plan, which is a common practice. There is no indication of positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions and provides transparency to the market regarding the trading activities of company executives. It is common for executives to utilize 10b5-1 trading plans to manage their stock holdings and avoid accusations of insider trading.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives.
- The use of 10b5-1 trading plans is a common strategy employed by executives at companies like Teladoc, GoodRx, and Amazon to manage their stock transactions while adhering to insider trading regulations.
- The reported prices are within the normal trading range for HIMS stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
- The filing provides transparency to stakeholders regarding insider trading activities.
Key Dates
| Date | Description |
|---|---|
| January 24, 2022 | Vesting Commencement Date for stock options. |
| May 31, 2024 | Date of adoption of Rule 10b5-1 trading plan. |
| October 02, 2024 | Date of stock option exercise and stock sales. |
| October 03, 2024 | Date of signature on the Form 4 filing. |
| February 23, 2032 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.